Mammoth Biosciences vs Nimbus Therapeutics
Mammoth Biosciences vs Nimbus Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mammoth Biosciences is on 63/100 and Nimbus Therapeutics on 51/100.
Where each one leads
Mammoth Biosciences
- our overall score: 63/100 against 51/100
- agent readiness: 35/100 against 27/100
Nimbus Therapeutics
- funding raised: $589M against $460M
At a glance
| Measure | Mammoth Biosciences | Nimbus Therapeutics |
|---|---|---|
| What it is | Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics. | Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines. |
| Category | Biotechnology, Drug Discovery, Genomics, CRISPR Technology | Biotechnology, Drug Discovery, AI, Machine Learning |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2009 |
| Headquarters | Brisbane, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Mammoth Biosciences | Nimbus Therapeutics |
|---|---|---|
| Employees | 165 | Not published |
| Headcount growthLast 12 months | +5.8% | Not published |
| Total funding | $460M | $589M |
| Latest round | Funding Round | Series F |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 57,986 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mammoth Biosciences | Nimbus Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 51/100 |
| Traction | 60/100 | 40/100 |
| Team | 70/100 | 30/100 |
| Community | Not published | 8/100 |
| Search visibility | 35/100 | 18/100 |
| Quality | 68/100 | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 55/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mammoth Biosciences | Nimbus Therapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Analytics 4, Segment, Microsoft Clarity |
Mammoth Biosciences vs Nimbus Therapeutics: common questions
Which is better, Mammoth Biosciences or Nimbus Therapeutics?
On our 0-100 score Mammoth Biosciences rates higher (63/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Mammoth Biosciences and Nimbus Therapeutics compare on the numbers?
Mammoth Biosciences leads on our overall score (63/100 against 51/100), agent readiness (35/100 against 27/100). Nimbus Therapeutics leads on funding raised ($589M against $460M).
Read the full Mammoth Biosciences review and pricing or the Nimbus Therapeutics review and pricing. You can also browse other Mammoth Biosciences alternatives we track.